ToplineGSK and Vir announced on Wednesday that sotrovimab, a monoclonal antibody used in the treatment of Covid-19 that the two companies developed together, has been granted Emergency Use Authorization by the U.S. FDA. Registered nurse treats coronavirus patient with Bamlanivimab, a monoclonal antibody. This is the third monoclonal antibody therapy that has been granted an EUA, following drugs from Regeneron and Lilly. Bamlanivimab, a monoclonal antibody by Lilly, was granted an EUA in November 2020. Bamlanivimab is still used to treat Covid-19 in combination with another monoclonal antibody, and Lilly also has another monoclonal antibody in development.

Source: Forbes May 26, 2021 22:52 UTC